Biotech Investors & VC Firms
2107 firms in this list, with a median first check of $500K. 405 of them lead rounds. Generated from verified public data and updated continuously.
Shastra VC
GurgaonPre-Seed–Series A$550K – $12M
11 people
Frontline Strategy Funds
SingaporeSeed–Growth$5M – $15M
2 people
1955 Capital
San FranciscoPre-Seed–Series A$5M – $10M
7 people
GENIUS Venture Capital
SchwerinPre-Seed–Series A$540K – $1.6M
4 people
Taiho Ventures, LLC
Menlo ParkSeed–Series B
7 people
3CC | Third Culture Capital
BostonPre-Seed–Series A$250K – $1M
6 people
Bonaventure Equity, LLC
RaleighPre-Seed–Series A
12 people
Flow Capital
TorontoGrowth–Late Stage
Lang Sheng Investment Group Co. Ltd.
ShanghaiPre-Seed–Series B
9 people
Prospect Venture Partners
Menlo ParkSeed–Late Stage$3M – $5M
3 people
TS Ventures
BelgradePre-Seed–Seed$27M
6 people
Aescap Life Sciences
AmsterdamSeed–Growth
14 people
Samho Green Investment, Inc.
SeoulSeed–Late Stage$500K – $10M
11 people
Sodero
NantesSeed–Late Stage$162K – $5.4M
11 people
Sugati Ventures
San RamonSeed–Series A
11 people
Netrix Ventures
Pre-Seed–Series A
2 people
ALIVE Israel HealthTech Fund
SavyonSeed–Late Stage
10 people
BlueTree Venture Capital
WexfordSeed–Series A
7 people
Elementum Ventures
San FranciscoPre-Seed–Seed$250K – $1.5M
4 people
TO VC
New YorkSeed–Series B
10 people
Welltech Ventures
Tel AvivSeed–Series A
10 people
Rex Health Ventures
RaleighSeed–Series B$250K – $500K
9 people
Positron Ventures
AmsterdamPre-Seed–Series A
8 people
The Vertical Group
Berkeley HeightsPre-Seed–Series B$250K – $5M
5 people
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.




























































